No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / Florida       

HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Category: MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Discover Reeva FT: Revolutionizing Wound...

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Summus Medical Laser | Launches...

The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.

Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

UltraViolet Devices: University of Siena Researchers Demonstrate Rapid UV Disinfection of Operating Rooms Between Surgeries

In the research, conducted by Dr. Gabriele Messina, Professor of Public Health, the University of Siena at the Rugani Hospital Monteriggioni in Siena, the UVDI-360 Room Sanitizer achieved a greater than 97% germ reduction in operating rooms in only six minutes, with two three-minute disinfection cycles run on each side of the operating table.

Medtronic Announces European Launch of World’s 1st Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes

This innovation doubles the length of time an infusion set can be worn so users can safely stay on insulin pump therapy with fewer interruptions and insertions while introducing enhanced convenience and comfort to their diabetes management routine.

BIOCORP and ROCHE DIABETES CARE FRANCE Launch Mallya, an Innovative Medical Device to Better the Daily Life of Patients With Diabetes

Manufactured in Clermont-Ferrand (France), this innovation for patients taking insulin is the first in its category to receive the CE-mark (medical device).

Nerivio Wearable Migraine Therapeutic Now Eligible for Insurance Coverage through UpScript’s Telemedicine Platform

“It is our mission to make Nerivio accessible to everyone who experiences migraine episodes,” said Theranica CEO Alon Ironi.

Carmafil Launches Newly Designed Guidewire Bowl – Now Commercially Available

Carmafil guidewire bowl was developed by vascular/endovascular neurosurgeon Dr. Cargill Alleyne.

Medtronic Announces Ongoing Initiatives to Address Health Equity for People of Color Living with Diabetes

The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.

The Medtronic Foundation and Children’s Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries

This partnership continues a rich collaborative legacy across the organizations and is made in honor of Omar Ishrak, former chairman and CEO, Medtronic and former board member of the Medtronic Foundation, a true champion of impact-driven philanthropy focusing on the underserved.

XIENCE Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

The approval follows recent results from two studies that demonstrated both one-month or three-month DAPT followed by aspirin monotherapy is safe in HBR patients and is intended to improve patient outcomes and provide physicians more options to treat their patients.

Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.

Strategic Device Partnership Allows Seelos to Use Aptar Pharma's Bidose (BDS) Liquid System Device with the SLS-002 Program (Intranasal Racemic Ketamine). Covers the Use of the BDS Liquid System for Intranasal Delivery of SLS-002 for the Treatment of Suicidality, Major Depressive Disorder and PTSD, and Agreement Provides Other Rights to Include Additional Undisclosed Indications

By using this website you agree to accept Medical Device News Magazine Privacy Policy